Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-28

FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a supplemental application for clomipramine hydrochloride from Sun Pharmaceutical Industries, authorizing changes to the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOMIPRAMINE HYDROCHLORIDE (clomipramine hydrochloride)

Snippet

SUPPL AP for CLOMIPRAMINE HYDROCHLORIDE (CLOMIPRAMINE HYDROCHLORIDE)